Macdonald, F. Rougieux, A. Cuevas, LY3023414 et al., Journal of Applied Physics 105, 093704 (2009)]. However, this dependency contradicts observations of LID in compensated n-type silicon wafers [T. Schutz-Kuchly, J. Veirman, S. Dubois, et al., Applied Physics Letters 96, 1 (2010)], which are confirmed in this study by investigating the boron-oxygen complex formation on a large variety of compensated p- and n-type samples. In spite of their high boron content, compensated n-type samples may show a less pronounced LID than p-type samples containing less boron. Our experiments indicate that in compensated silicon, the defect concentration is only a function
of the compensation ratio R(C) = (N(A) + N(D))/(N(A) – N(D)). (C) 2011 American Institute of Physics. [doi:10.1063/1.3552302]“
“Obesity has reached epidemic proportions in the USA. Consequently, there is an increasing number of obese diabetic patients who would otherwise be appropriate learn more candidates for pancreas transplantation (PTx). This is a retrospective study of all PTx performed at Indiana University between 2003 and 2009 (n = 308) comparing recipients with body mass index (BMI) < 25, 25-29.9, and >= 30 kg/m(2) Data included recipient and donor demographics, seven and 90-d graft loss, one-yr pancreas, kidney (for SPK only) and patient survival, causes of graft
loss and death, peak amylase and lipase, length of stay, readmissions, complications, HbA1C, and c-peptide. Of the 308 PTx, 100 (32%) were overweight and 42 (14%) were obese. Obese recipients were older and more likely to be men. Donor demographics were similar. There was no difference in seven-d or 90-d graft loss, one-yr pancreas, kidney or patient survival, cause of graft loss or death, 30-d peak amylase or lipase, HbA1C, or C-peptide. The incidence of post-transplant technical, immunological and infectious complications was similar except for an increased
incidence of cytomegalovirus infection in the obese group. Two recipients returned to insulin therapy despite normal C-peptide levels. Although technically challenging, PTx can be successful in select obese recipients with similar results compared to normal BAY 63-2521 BMI recipients.”
“Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with encephalitis is a life-threatening condition that requires treatment with immunochemotherapy; refractory patients are eligible for allogeneic hematopoietic stem cell transplantation. We report on an adolescent female who failed to respond to induction immunochemotherapy and was salvaged by allogeneic hematopoietic stem cell transplantation from her human leukocyte antigen-identical, Epstein-Barr virus-seropositive brother leading to rapid clearance of Epstein-Barr virus from blood and cerebrospinal fluid.